Avanos Medical (AVNS) investor reports 0% beneficial ownership in update

Rhea-AI Filing Summary

Avanos Medical, Inc. received an updated ownership report showing that Robert G. Moses Capital, LLC now reports beneficial ownership of 0 shares of Avanos common stock, representing 0.0% of the outstanding class as of 12/31/2025.

The filer confirms it owns 5 percent or less of the stock class and has no sole or shared power to vote or dispose of any shares. It also certifies that any securities referenced were acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Avanos Medical.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

AVANOS MEDICAL, INC.

(Name of Issuer)

Common Stock, $0.01 Par Value

(Title of Class of Securities)

05350V106

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 05350V106

1

Names of Reporting Persons

RGM Capital, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: AVANOS MEDICAL, INC.
(b)	Address of issuer's principal executive offices: 5405 WINDWARD PARKWAY, SUITE 100 SOUTH, ALPHARETTA, GEORGIA, 30004
Item 2.
(a)	Name of person filing: Robert G. Moses RGM Capital, LLC
(b)	Address or principal business office or, if none, residence: 9010 Strada Stell Court, Suite 105, Naples, FL 34109
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock, $0.01 Par Value
(e)	CUSIP No.: 05350V106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

RGM Capital, LLC

Signature:	Robert G. Moses
Name/Title:	Managing Member
Date:	02/13/2026

FAQ

What does the latest Schedule 13G/A filing for AVNS show about ownership?

The filing shows that Robert G. Moses Capital, LLC now reports beneficial ownership of 0 shares of Avanos Medical common stock, representing 0.0% of the class as of 12/31/2025.

Who is the reporting person in the AVNS Schedule 13G/A amendment?

The reporting person is Robert G. Moses Capital, LLC, a Delaware entity with its principal business office at 9010 Strada Stell Court, Suite 105, Naples, FL 34109, reporting on holdings of Avanos Medical common stock.

How many AVNS shares does the reporting person control after this amendment?

The reporting person states it has no sole or shared voting power and no sole or shared dispositive power over any Avanos Medical shares, with aggregate beneficial ownership reported as 0 shares.

What percentage of Avanos Medical (AVNS) stock is reported as owned?

The amended Schedule 13G reports that 0.0% of Avanos Medical’s common stock is beneficially owned by the reporting person, reflecting ownership of 5 percent or less of the outstanding class.

What does the certification in the AVNS Schedule 13G/A say?

The certification states the securities were acquired and are held in the ordinary course of business, not for the purpose or effect of changing or influencing control of Avanos Medical, and not as part of a control-related transaction.

What class of AVNS securities is covered in this ownership report?

The filing covers common stock, $0.01 par value, of Avanos Medical, Inc., identified by CUSIP 05350V106, and confirms the reporting person currently has no beneficial ownership in this class.